SLC25A20 and hepatocellular carcinoma: To further determine whether SLC25A20 suppressed HCC growth and metastasis through induction of fatty-acid oxidation, fatty-acid oxidation was inhibited by using etomoxir, an inhibitor of fatty-acid oxidation through targeting carnitine pamitoyltransferase-1 (CPT1).